Page 3 - Michael Halstead News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Polar Capital Holdings Plc increased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 150.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,000,000 shares of the biopharmaceutical company’s stock after buying an additional 600,000 shares during the quarter. […]

Polar Capital Holdings Plc lifted its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 150.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,000,000 shares of the biopharmaceutical company’s stock after purchasing an additional 600,000 shares during the quarter. Polar Capital Holdings […]

Michael Halstead, EVP and General Counsel of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold 7,907 shares of the company on February 26, 2024, according to a recent SEC Filing.

Profund Advisors LLC grew its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 10.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,132 shares of the biopharmaceutical company’s stock after acquiring an additional 1,135 shares during the period. Profund Advisors LLC’s holdings […]

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.14, Briefing.com reports. Intra-Cellular Therapies had a negative return on equity of 22.83% and a negative net margin of 30.08%. The company had […]